-
Mashup Score: 0
Researchers have used AI to evaluate ECGs in a targeted strategy to screen for atrial AF.
Source: Cardiac Rhythm NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1New data hint at “hard to beat” efficacy and safety for rotational TLE - Cardiac Rhythm News - 2 year(s) ago
Data from the PROMET and RELEASE studies provide important new insights into the safety and efficacy of rotational transvenous lead extraction (TLE), Christoph Starck (Berlin, Germany) and Peter Paul Delnoy (Zwolle, The Netherlands) tell Cardiac Rhythm News at the 2022 European Heart Rhythm Association annual meeting (EHRA 2022, 3‒5 April, Copenhagen, Denmark).
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ESC 2022: Findings of CAPLA trial “do not support inclusion of posterior wall isolation” for persistent AF - 2 year(s) ago
The addition of posterior wall isolation does not improve arrhythmia outcomes compared with PVI alone in patients undergoing first time ablation for persistent AF.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Medtronic has announced that it has completed the acquisition of Affera. The acquisition will expand Medtronic’s cardiac ablation portfolio to include its first cardiac mapping and navigation platform.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Screening for atrial fibrillation (AF) using a smartphone app more than doubled the detection and treatment rate in older people compared to routine screening.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
New guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death have been published in the European Heart Journal.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0FDA approves clinical trial of SERF ablation for VT patients - 2 year(s) ago
Thermedical has announced that the FDA has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical SERF ablation system in people with VT resistant to conventional treatment.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Recent AF diagnosis and multiple comorbidities warrants early rhythm control strategy - 2 year(s) ago
Patients with recently diagnosed AF with a high burden of comorbidities should be considered for early rhythm control to reduce cardiovascular outcomes.
Source: Cardiac Rhythm NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0First-in-man study yields promising results for saline-enhanced radio frequency VT ablation - Cardiac Rhythm News - 2 year(s) ago
A first-in-human multicentre trial using in-catheter, heated saline-enhanced radio frequency (SERF) ablation for patients with ventricular tachycardia (VT) has reported that the technique showed complete acute and satisfactory mid-term control of difficult VTs, which had failed one to five prior ablations and drug therapy. The findings of the first-in-man feasibility trial were published in a […]
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5“Worrisome” rise in cardiovascular disease predicted out to 2060 - Cardiac Rhythm News - 2 year(s) ago
Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by 2060, a study published in the Journal of the American College of Cardiology (JACC) has claimed. Substantial increases in cardiovascular trends may contribute to a rising burden on the US healthcare system and highlight the need for equitable access to […]
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
#AI algorithm identifies hidden #AFib cases in screening study https://t.co/N7FxNTbVYk via @CRN_publishing